Geneticin™ selective antibiotic (G418 sulfate) produced by the bacterium Micromonospora rubrum , inhibiting protein synthesis by binding to ribosomes in prokaryotic and eukaryotic cells. Geneticin™ selective antibiotic (G418 sulfate) resistance can be obtained by carrying the E. coli APH (3') – I and APH (3') – II resistance genes. Gibco™ Geneticin™ Selective Antibiotic (G418 Sulfate) is used as a selective antibiotic in the concentration range 100 - 200 µg/mL when used on bacteria and in the concentration range 200 - 500 µg/mL when used on most mammalian cells mL. This product is supplied as a 50 mg/mL aqueous solution. We offer a variety of Cell Culture AntibioticsEasy to use.

Product Use
Research Use Only: Not intended for diagnostic or therapeutic use in animals or humans.

GMP manufacturing and quality standards in both locations
Gibco™ Geneticin™ selective antibiotic (G418 sulfate) is manufactured in a cGMP compliant facility in Grand Island, New York . The factory is an FDA-registered medical device manufacturer and is certified to the ISO 13485 standard. To ensure supply chain stability, we also offer the same Gibco™ Geneticin™ selective antibiotic (G418 sulfate) (10131-019) produced in our Scottish facility. The latter is also a medical device manufacturer registered with the FDA and complies with the ISO 13485 standard.